Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Occidental Petroleum Corporation | WES Western Midstream Partners, LP | 13D/A | 43.5% | Aug 12, 2024 | 2y |
| Triton LuxTopHolding SARL | VSAT Viasat Inc | 13D/A | 6.69% | Aug 12, 2024 | 2y |
| Casdin Capital, LLC | LAB Standard Biotools Inc. | 13D/A | 19.77% | Aug 12, 2024 | 2y |
| Ocho Investments LLC | TBRG TruBridge, Inc. | 13D | 5.7% | Aug 9, 2024 | 2y |
| Senvest Management, LLC | LOVE Lovesac Co | 13G | 5.3% | Aug 9, 2024 | 2y |
| JANUS HENDERSON GROUP PLC | SKYE Skye Bioscience, Inc. | 13G | 5.7% | Aug 9, 2024 | 2y |
| 325 CAPITAL LLC | MPAA Motorcar Parts Of America Inc | 13D/A | 8.5% | Aug 8, 2024 | 2y |
| Vivo Opportunity Fund Holdings, L.P. | TENX Tenax Therapeutics, Inc. | 13G | 9.99% | Aug 8, 2024 | 2y |
| JANUS HENDERSON GROUP PLC | TENX Tenax Therapeutics, Inc. | 13G | 9.9% | Aug 8, 2024 | 2y |
| BML Investment Partners, L.P. | TLIS Talis Biomedical Corporation Common Stock | 13G | 7.4% | Aug 7, 2024 | 2y |
| Millennium Management LLC | RVPH Reviva Pharmaceuticals Holdings, Inc. | 13G | 5.2% | Aug 6, 2024 | 2y |
| Rosalind Advisors, Inc. | PYPD PolyPid Ltd. | 13G/A | 9.9% | Aug 6, 2024 | 2y |
| Aspex Management (HK) Ltd | FUTU Futu Holdings Ltd | 13G | 5% | Aug 6, 2024 | 2y |
| NEEDHAM INVESTMENT MANAGEMENT LLC | ODC Oil-Dri Corp of America | 13G | 5.07% | Aug 5, 2024 | 2y |
| block.one | TRNR Interactive Strength, Inc. | 13D/A | 2.1% | Aug 2, 2024 | 2y |
| Rosalind Advisors, Inc. | CLRB Cellectar Biosciences, Inc. | 13G/A | 9.9% | Jul 25, 2024 | 2y |
| Gaderway Investments Limited | MFI mF International Ltd | 13G | 68.3% | Jun 30, 2024 | 2y |
| Affinity Asset Advisors, LLC | CLYM Climb Bio, Inc. | 13G/A | 2.7% | Jun 30, 2024 | 2y |
| Mark N. Tompkins | GUER Guerrilla RF, Inc. | 13G/A | 4.2% | Jun 30, 2024 | 2y |
| Caledonia (Private) Investments Pty Ltd | LAWIL Light & Wonder, Inc. | 13G/A | 9.44% | Jun 30, 2024 | 2y |
| AMERICAN CAPITAL MANAGEMENT INC | CRNC Cerence Inc. | 13G | 9.3% | Jun 30, 2024 | 2y |
| Mark N. Tompkins | SERV Serve Robotics Inc. | 13G/A | 4.9% | Jun 30, 2024 | 2y |
| Bellevue Capital Management LLC | OSRH OSR Health, Inc. | 13G/A | 50.4% | Jun 30, 2024 | 2y |
| Illumina, Inc. | GRAL GRAIL, Inc. | 13G | 14.5% | Jun 30, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | NPFD Nuveen Variable Rate Preferred & Income Fund | 13G | 5.42% | Jun 28, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | EMO ClearBridge Energy Midstream Opportunity Fund Inc. | 13G/A | 1.71% | Jun 28, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | GLO Clough Global Opportunities Fund | 13G | 5.06% | Jun 28, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | VBF Invesco Bond Fund | 13G/A | 3.85% | Jun 28, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | VGM Invesco Trust for Investment Grade Municipals | 13G | 5.68% | Jun 28, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | ZTR Virtus Total Return Fund Inc. | 13G/A | 3.58% | Jun 5, 2024 | 2y |
| Bradbury Strategic Investment Fund A | IGC IGC Pharma, Inc. | 13D/A | 18.3% | Mar 22, 2024 | 2y |
| EMS Capital LP | AGRO Adecoagro S.A. | 13G/A | 0% | Aug 13, 2024 | 2y |
| Sachem Head Capital Management LP | USFD US Foods Holding Corp. | 13D/A | 4% | Aug 13, 2024 | 2y |
| Jason Katz | IPM Intelligent Protection Management Corp. | 13D/A | 7.5% | Aug 13, 2024 | 2y |
| OR Nazar M. Khan | WULF Terawulf Inc. | 13D/A | 7.27% | Aug 12, 2024 | 2y |
| MMCAP International Inc. SPC | VACH Voyager Acquisition Corp. | 13G | 5% | Aug 12, 2024 | 2y |
| 3G Restaurant Brands Holdings General Partner Ltd. | QSR Restaurant Brands International Inc. | 13D/A | 28% | Aug 12, 2024 | 2y |
| Sanofi | MGTX MeiraGTx Holdings plc | 13G/A | 15.8% | Aug 12, 2024 | 2y |
| JAB Holdings B.V. | DNUT Krispy Kreme, Inc. | 13D/A | 44.15% | Aug 12, 2024 | 2y |
| KAISER GEORGE B | ALKT Alkami Technology, Inc. | 13G/A | 11.06% | Aug 12, 2024 | 2y |
| Elliott Investment Management L.P. | LUV Southwest Airlines Co | 13D/A | 8.2% | Aug 9, 2024 | 2y |
| Frank Porter Stansberry | MKTW Marketwise, Inc. | 13D/A | 60.9% | Aug 9, 2024 | 2y |
| CIIG Management III LLC | CPTKW Crown PropTech Acquisitions | 13D/A | 76.4% | Aug 9, 2024 | 2y |
| Liberty 77 Capital L.P. | STRZ Starz Entertainment Corp | 13D/A | 15.9% | Aug 9, 2024 | 2y |
| Logos Global Management LP | DSGN Design Therapeutics, Inc. | 13D/A | 7.5% | Aug 9, 2024 | 2y |
| CPC Pain & Wellness SPV, LLC | XWEL XWELL, Inc. | 13D/A | 7.5% | Aug 9, 2024 | 2y |
| Fund 1 Investments, LLC | DXLG Destination XL Group, Inc. | 13D/A | 9.8% | Aug 9, 2024 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | ANTX AN2 Therapeutics, Inc. | 13G/A | 6.7% | Aug 9, 2024 | 2y |
| RANDAL J. KIRK | PGEN Precigen, Inc. | 13D/A | 40.5% | Aug 9, 2024 | 2y |
| Ridgemont Equity Partners Affiliates III, L.P. | KRP Kimbell Royalty Partners, LP | 13G/A | 4% | Aug 8, 2024 | 2y |